Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Different roads to diabetes

08.11.2010
A specific genetic variant puts individuals of Asian ancestry at risk of developing diabetes—but not their European counterparts

Type 2 diabetes is relatively widespread in Japan, and that nation’s Ministry of Health, Labour and Welfare estimates that nearly one-third of all individuals over the age of 40 are either diabetic or pre-diabetic.

Intriguingly, Japanese patients as a whole are less prone to obesity, a condition commonly associated with onset of type 2 diabetes in the Western world, indicating that there may be some significant differences in disease pathology between these two groups.

Two primary mechanisms contribute to the onset of type 2 diabetes. Fat, muscle and liver cells lose the ability to respond to the hormone insulin, a state known as ‘insulin resistance’ that greatly reduces the efficiency with which excess glucose is taken up from the bloodstream; in parallel, the capacity of the pancreatic beta cells to produce and secrete additional insulin is impaired.

However, Shiro Maeda of the RIKEN Center for Genomic Medicine in Yokohama points out that the relative importance of these mechanisms appears to differ between Eastern and Western populations. “Accumulating clinical evidence suggests that disability of insulin secretion contributes more to the pathogenesis of Japanese type 2 diabetes,” he says, “whereas insulin resistance seems more important for European type 2 diabetes.”

Getting the big picture

Very little is known about the genetic-level differences in pathology between the Japanese and Europeans. From several previous genome-wide association studies (GWAS), geneticists have identified several small sequence changes, also known as single-nucleotide polymorphisms (SNPs), which might be located near or within genes involved in type 2 diabetes. They have also identified several of these ‘susceptibility loci’. However, with the exception of a few small-scale Japanese studies, nearly all of these data were obtained exclusively from individuals of European ancestry.

In an effort to collect more information about Japanese-specific risk factors, Maeda and Takashi Kadowaki of The University of Tokyo recently headed up a large GWAS that matches the scale of its European counterparts both in terms of the numbers of subjects involved and in the number of genomic markers examined1. According to Maeda, their study of some 5,000 type 2 diabetes subjects and 3,000 controls for 459,359 SNPs, is one of the largest sample sizes for a single GWAS worldwide.

Maeda, Kadowaki and colleagues subjected 98 candidate SNPs with the strongest association to type 2 diabetes to an additional round of analysis in a second, independent, set of disease and control cohorts. Based on these data, they identified statistically significant disease linkage for SNPs at a number of different genomic loci (Fig. 2). One of these SNPs, KCNQ1, was identified in both of the previous Japanese GWAS as a risk factor in both Asians and Europeans, and this gene appears to participate in the regulation of glucose-induced insulin secretion.

The researchers’ study also flagged SNPs at two additional loci for which no association to type 2 diabetes had been previously reported. Both of these loci were subsequently validated in yet a third round of genomic screening, reinforcing the likelihood of their connection to diabetes.

Enigmatic risk factors

One of the newly identified loci, UBE2E2, encodes an enzyme that targets proteins for destruction by marking them with individual molecules of the small protein ubiquitin. It is expressed in a variety of tissues, including the liver, pancreas, muscle and fat. Based on several recent studies, researchers have suggested that the ubiquitination pathway may contribute to the efficient synthesis and secretion of insulin. Maeda, Kadowaki and colleagues noted that study subjects with the diabetes risk-associated UBE2E2 allele appeared to exhibit impairments in insulin regulation.

Strikingly, although the SNPs at this locus were also determined to be associated with type 2 diabetes for three other East Asian populations, in addition to various Japanese study groups, this association was not statistically significant for two European groups, consisting of a total of 6,980 subjects and 8,615 controls. “Although this population-specific effect needs to be validated further, the present study is the first to show the existence of a disease-susceptibility locus [for diabetes] in a population-specific manner with genome-wide significant levels of association,” says Maeda.

Despite escaping detection in previous large-scale GWAS, the second newly identified locus, C2CD4A-C2CD4B, showed significant association with type 2 diabetes in both Asian and European cohorts. C2CD4A-C2CD4B produces a pair of factors that appear to contribute to the maintenance of cell structure, and although relatively little is known about their function, both factors are expressed in many of the same tissues as UBE2E2. This represents the first indication that they might contribute to the pathology of type 2 diabetes.

Digging deeper

Kadowaki, Maeda and colleagues are now scanning these two loci more carefully in an effort to identify potential mechanisms by which sequence variants in these regions might contribute to onset of diabetes. Maeda indicates that they are particularly keen to understand the biological basis for the apparent ethnicity-specific disease association of SNPs in the UBE2E2 locus.

At the same time, the identification of a novel locus that appears to contribute to risk of diabetes across population lines suggests that there may be a number of other susceptibility genes waiting to be discovered. “The identification of C2CD4A-C2CD4B as a common locus is really surprising, because this important locus has been missed in European GWAS,” says Maeda, “[and] we are now participating in international collaborations, both East Asian and trans-ethnic, to identify additional type 2 diabetes susceptibility loci.”

Shiro Maeda

Shiro Maeda was born in 1960 and is currently Laboratory Head at the Laboratory for Endocrinology and Metabolism, RIKEN Center for Genomic Medicine, where his research area is genetics for diabetic nephropathy and type 2 diabetes. He received his MD and PhD from Shiga University of Medical Science. He worked as a physician at Koka Public Hospital and Shiga University of Medical Science for next three years. From 1993 to 1996 he was a research fellow at the Department of Pathology, University of Michigan, where he researched osmotic response elements within the ALR2 gene. For the next two years, he did a residency at Shiga University of Medical Science in internal medicine, and emergency and critical medicine. In 1999, he was an instructor for the Third Department of Medicine, Shiga University of Medical Science, and then joined RIKEN the following year as a research scientist in the Laboratory for Genotyping, SNP Research Center. He was a Laboratory head at Laboratory for Diabetic Nephropathy between 2001 and 2008, and has been in his current post since 2008.

Journal information
Yamauchi, T., Hara, K., Maeda, S., Yasuda, K., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., Grarup, N., Cauchi, S. et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nature Genetics 42, 864–868 (2010).

gro-pr | Research asia research news
Further information:
http://www.rikenresearch.riken.jp/eng/hom/6439
http://www.researchsea.com

More articles from Life Sciences:

nachricht New technique unveils 'matrix' inside tissues and tumors
29.06.2017 | University of Copenhagen The Faculty of Health and Medical Sciences

nachricht Designed proteins to treat muscular dystrophy
29.06.2017 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making Waves

Computer scientists use wave packet theory to develop realistic, detailed water wave simulations in real time. Their results will be presented at this year’s SIGGRAPH conference.

Think about the last time you were at a lake, river, or the ocean. Remember the ripples of the water, the waves crashing against the rocks, the wake following...

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Nanostructures taste the rainbow

29.06.2017 | Physics and Astronomy

New technique unveils 'matrix' inside tissues and tumors

29.06.2017 | Life Sciences

Cystic fibrosis alters the structure of mucus in airways

29.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>